Gabapentin Safety Questions, Gabapentin Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Gabapentin side effects. Check out Health Surveys and Health Polls. If you have questions about Gabapentin, you can post them to our Doctors or Ask Patient Community about Gabapentin.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Gabapentin
Gabapentin Safety Reports
Total Gabapentin reports: 347.Gabapentin FDA safety alerts: 2005 2008 .
Reported deaths: 41 Reported hospitalizations: 123.
Take Gabapentin Side Effects Survey or Share Your Gabapentin Story.
Reported Gabapentin Side Effects: confusional state, condition aggravated, depression, tremor, myotonia, agitation, dystonia, hyperhidrosis, dizziness, somnolence, sinus tachycardia.
Gabapentin Usage.
< Previous Showing 101-150 of 347 Next >
Gabapentin Side Effects Report #5352194-1Health Professional from UNITED KINGDOM reported GABAPENTIN problem on May 23, 2007. Male patient, 64 years of age, weighting 207.2 lb, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: acute coronary syndrome, blood pressure fluctuation, memory impairment, road traffic accident, syncope. GABAPENTIN dosage: 600 MG, QID, ORAL. During the same period patient was treated with ASPIRIN, BISOPROLOL FUMARATE, ELANTAN LA, LANSOPRAZOLE, LISINOPRIL, SIMVASTATIN. Patient recovered.
Gabapentin Side Effects Report #5353600-9
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on May 24, 2007. Female patient, 66 years of age, was diagnosed with abdominal pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: metastases to lung, metastatic neoplasm, ovarian cancer. GABAPENTIN dosage: 600 MG, TID, ORAL. Patient died.
Gabapentin Side Effects Report #5354795-3
Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA reported GABAPENTIN problem on June 05, 2007. Female patient, 34 years of age, was diagnosed with epilepsy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: accidental overdose, areflexia, cerebral atrophy, cerebral ventricle dilatation, convulsion, muscle twitching, status epilepticus. GABAPENTIN dosage: 5400 MG, QD;. During the same period patient was treated with DEPARKIN, SABRIL. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5357258-4
GABAPENTIN problem was reported by a Physician from SPAIN on May 28, 2007. Female patient, 74 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, depressed level of consciousness, hypersomnia, hypoventilation, respiratory depression. GABAPENTIN dosage: unknown. During the same period patient was treated with IPRATROPIUM BROMIDE, SALMETEROL, FLUTICASONE PROPIONATE. Patient recovered.
Gabapentin Side Effects Report #5357571-0
Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on June 04, 2007. Male patient, 33 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, disorientation, hyperhidrosis, hyperreflexia, tachycardia, tremor. GABAPENTIN dosage: DAILY DOSE:3600MG. During the same period patient was treated with PAROXETINE, QUETIAPINE. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5359472-0
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 04, 2007. Female patient, 88 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, mania, paranoia. GABAPENTIN dosage: unknown. During the same period patient was treated with RANITIDINE, BENDROFLUMETHIAZIDE, DICLOFENAC, DOMPERIDONE, LEVOTHYROXINE, MOVICOL, OXYCONTIN. Patient was hospitalized and became disabled. Patient recovered.
Gabapentin Side Effects Report #5360988-1
Consumer or non-health professional from TURKEY reported GABAPENTIN problem on June 06, 2007. Female patient, 35 years of age, was diagnosed with pain in extremity, neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: breast mass, carcinoembryonic antigen increased. GABAPENTIN dosage: unknown. During the same period patient was treated with PREGABALIN, TRAMADOL, DIAZEPAM, DICLOFENAC. Patient recovered.
Gabapentin Side Effects Report #5361325-9
GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 01, 2007. Female patient, 68 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, coordination abnormal, mania, paranoia. GABAPENTIN dosage: unknown. During the same period patient was treated with RANITIDINE, BENDROFLUMETHIAZIDE. Patient was hospitalized and became disabled. Patient recovered.
Gabapentin Side Effects Report #5363508-0
Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 01, 2007. Female patient, 86 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: cerebellar ataxia, mania, paranoia. GABAPENTIN dosage: unknown. During the same period patient was treated with RANITIDINE, BENDROFLUMETHIAZIDE, DICLOFENAC, DOMPERIDONE, LEVOTHYROXINE, MOVICOL, OXYCONTIN. Patient was hospitalized and became disabled. Patient recovered.
Gabapentin Side Effects Report #5366339-0
GABAPENTIN problem was reported by a Pharmacist from UNITED STATES on June 20, 2007. Female patient, 38 years of age, was diagnosed with neuralgia, pain in extremity, procedural pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dizziness, tinnitus. GABAPENTIN dosage: unknown. Patient recovered.
Gabapentin Side Effects Report #5366992-1
Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 07, 2007. Female patient was diagnosed with convulsion and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, neuropathy peripheral. GABAPENTIN dosage: unknown. Patient recovered.
Gabapentin Side Effects Report #5367821-2
GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 12, 2007. Male patient, 75 years of age, was diagnosed with neuralgia, parkinson's disease and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: choreoathetosis, dyskinesia, lumbar spinal stenosis. GABAPENTIN dosage: unknown. During the same period patient was treated with ENTACAPONE, CARBIDOPA, LEVODOPA. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5368061-3
Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on June 13, 2007. Female patient, 45 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: gastric disorder, nausea, pain. GABAPENTIN dosage: unknown. Patient recovered.
Gabapentin Side Effects Report #5368402-7
GABAPENTIN problem was reported by a Physician from SPAIN on June 08, 2007. Female patient, 74 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, depressed level of consciousness, hypersomnia, hypoventilation, poor quality sleep, respiratory depression. GABAPENTIN dosage: unknown. During the same period patient was treated with IPRATROPIUM BROMIDE, SALMETEROL, FLUTICASONE, CORTICOSTEROIDS, LEVOFLOXACIN. Patient recovered.
Gabapentin Side Effects Report #5369712-X
Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on June 08, 2007. Female patient, 63 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: jaundice. GABAPENTIN dosage: 100 MG; BID. During the same period patient was treated with PREGABALIN, SIMVASTATIN, OXYBUTYNIN, BACLOFEN. Patient recovered.
Gabapentin Side Effects Report #5369733-7
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 14, 2007. Female patient, 55 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dystonia, myotonia. GABAPENTIN dosage: unknown. During the same period patient was treated with SEVOFLURANE, CODEINE SUL, DEXAMETHASONE, FENTANYL, OXYGEN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5369876-8
Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 08, 2007. Female patient, 63 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: jaundice. GABAPENTIN dosage: unknown. During the same period patient was treated with LYRICA, BACLOFEN, OXYBUTYNIN, SIMVASTATIN. Patient recovered.
Gabapentin Side Effects Report #5371671-0
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 13, 2007. Female patient, 55 years of age, weighting 132.3 lb, was diagnosed with neuralgia, osteotomy, varicose vein operation and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dystonia, myotonia, sinus tachycardia. GABAPENTIN dosage: 600 MG, TID. During the same period patient was treated with ALFENTANIL, FENTANYL, PROPOFOL, ISOFLURANE, SEVOFLURANE. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5371847-2
Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on June 15, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. GABAPENTIN dosage: 100 MG; TID; PO. During the same period patient was treated with FELODIPINE, LEVODOPA W. Patient recovered.
Gabapentin Side Effects Report #5372750-4
GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 15, 2007. Female patient, 64 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: alopecia, appendicitis perforated, surgery. GABAPENTIN dosage: unknown. During the same period patient was treated with TRIMIPRAMINE MALEATE, HORMONES. Patient recovered.
Gabapentin Side Effects Report #5372756-5
Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on June 15, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. GABAPENTIN dosage: 100 MG, TID, ORAL. During the same period patient was treated with FELODIPINE, MADOPAR CR. Patient recovered.
Gabapentin Side Effects Report #5373815-3
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on June 18, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: parkinson's disease. GABAPENTIN dosage: unknown. During the same period patient was treated with FELODIPINE, MADOPAR. Patient recovered.
Gabapentin Side Effects Report #5375502-4
Consumer or non-health professional from UKRAINE reported GABAPENTIN problem on June 18, 2007. Female patient, weighting 125.7 lb, was diagnosed with diabetic neuropathy, pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: brain contusion, lower limb fracture, mental disorder, suicide attempt. GABAPENTIN dosage: unknown. During the same period patient was treated with ALPHA LIPOIC ACID, MILGAMMA, NOVORAPID, LANTUS. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5376181-2
GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 18, 2007. Male patient, 76 years of age, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, parkinson's disease. GABAPENTIN dosage: 300 MG (100 MG, 3 IN 1 D). Patient recovered.
Gabapentin Side Effects Report #5049111-0
Physician from TURKEY reported GABAPENTIN problem on June 23, 2006. Female patient, 69 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, gastroenteritis, loss of consciousness, myoclonus, paraesthesia. GABAPENTIN dosage: 900 MG (1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE, CANDESARTAN CILEXETIL, DEXAMETHASONE, TRAMADOL. Patient died on 06/01/2006.
Gabapentin Side Effects Report #5049787-8
GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2006. Female patient, weighting 154.0 lb, was diagnosed with neuropathy peripheral and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: poor peripheral circulation. GABAPENTIN dosage: 1600 MG (800 MG, 2 IN 1 D). During the same period patient was treated with CAMPRAL, PROMETRIUM, NITROFURAN. Patient recovered.
Gabapentin Side Effects Report #5050806-3
Health Professional from UNITED KINGDOM reported GABAPENTIN problem on June 26, 2006. Female patient, 29 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: fall, sensory loss, thermal burn. GABAPENTIN dosage: 800 MG, TID, ORAL. During the same period patient was treated with CLONAZEPAM. Patient recovered.
Gabapentin Side Effects Report #5051757-0
GABAPENTIN problem was reported by a Pharmacist from UNITED STATES on July 13, 2006. Male patient, weighting 216.0 lb, was diagnosed with neuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: nocturia. GABAPENTIN dosage: unknown. Patient recovered.
Gabapentin Side Effects Report #5056209-X
Physician from TURKEY reported GABAPENTIN problem on July 06, 2006. Female patient, 69 years of age, was diagnosed with trigeminal neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, gastroenteritis, loss of consciousness, myoclonus, paraesthesia, somnolence. GABAPENTIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE, CANDESARTAN CILEXETIL, DEXAMETHASONE, TRAMADOL. Patient died on 06/01/2006.
Gabapentin Side Effects Report #5061276-3
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on July 12, 2006. Female patient, 66 years of age, was diagnosed with abdominal pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, metastatic neoplasm, visual acuity reduced transiently. GABAPENTIN dosage: 18900 MG (600 MG, 3 IN 1 D), ORAL. Patient died.
Gabapentin Side Effects Report #5063261-4
Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on July 24, 2006. Male patient, 47 years of age, weighting 157.0 lb, was diagnosed with neuropathy peripheral and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: morbid thoughts, personality change, suicidal ideation. GABAPENTIN dosage: 3000MG PER DAY PO. Patient recovered.
Gabapentin Side Effects Report #5065101-6
GABAPENTIN problem was reported by a Physician from UNITED STATES on July 27, 2006. Male patient, weighting 156.0 lb, was diagnosed with neuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: mental status changes. GABAPENTIN dosage: 400 MG DAILY BUCCAL. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5065359-3
Consumer or non-health professional from GERMANY reported GABAPENTIN problem on July 03, 2006. Male patient, 66 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abasia, areflexia, blood creatinine increased, blood urea increased, dysarthria, dyskinesia, dysstasia, extensor plantar response. GABAPENTIN dosage: 900 MG, SINGLE,. Patient recovered.
Gabapentin Side Effects Report #5070190-9
GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 02, 2006. Male patient, 64 years of age, weighting 193.0 lb, was diagnosed with neuropathy peripheral and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dizziness, feeling abnormal. GABAPENTIN dosage: 800 MG TID [LIFETIME]. Patient recovered.
Gabapentin Side Effects Report #5072175-5
Consumer or non-health professional from UNITED STATES reported GABAPENTIN problem on July 19, 2006. Female patient, 61 years of age, weighting 150.0 lb, was diagnosed with complex regional pain syndrome and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: aspiration, cardiac disorder, complex regional pain syndrome, condition aggravated, dyspnoea, fall, foot fracture, nausea, vomiting. GABAPENTIN dosage: 1200 MG (600 MG, 2 IN 1 D),. During the same period patient was treated with DARVOCET. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5073443-3
GABAPENTIN problem was reported by a Physician from UNITED KINGDOM on July 24, 2006. Female patient, 21 years of age, weighting 92.59 lb, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: catatonia, delusion, hallucination, auditory, psychotic disorder, stereotypy, stupor. GABAPENTIN dosage: 2.4 GRAM (300 MG,8 IN 1 D), ORAL. During the same period patient was treated with MEFENAMIC ACID. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5082078-8
Physician from TURKEY reported GABAPENTIN problem on Aug 02, 2006. Female patient, 69 years of age, was diagnosed with trigeminal neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, gastroenteritis, loss of consciousness, myoclonus, paraesthesia, somnolence. GABAPENTIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE, CANDESARTAN CILEXETIL, DEXAMETHASONE, TRAMADOL, HYDROCHLOROTHIAZIDE. Patient died on 06/22/2006.
Gabapentin Side Effects Report #5082234-9
GABAPENTIN problem was reported by a Health Professional from UNITED STATES on Aug 15, 2006. Female patient, 55 years of age, weighting 155.0 lb, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. GABAPENTIN dosage: unknown. Patient recovered.
Gabapentin Side Effects Report #5084395-4
Pharmacist from UNITED STATES reported GABAPENTIN problem on Aug 17, 2006. Male patient, weighting 500.4 lb, was diagnosed with neuropathy peripheral, polyneuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: abnormal dreams, anxiety disorder, nightmare. GABAPENTIN dosage: 300 MG TID PO. During the same period patient was treated with ALBUTEROL SULPHATE AND IPRATROPIUM BROMIDE, CALCIUM 250MG, DARBEPOETIN ALFA, LANOXIN, DULOXETINE, FELODIPINE. Patient recovered.
Gabapentin Side Effects Report #5085935-1
GABAPENTIN problem was reported by a Physician from TURKEY on Aug 08, 2006. Female patient was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: dark circles under eyes, loss of consciousness, somatisation disorder. GABAPENTIN dosage: 900 MG 300 MG, 3 IN 1 D), ORAL. Patient recovered.
Gabapentin Side Effects Report #5086987-5
Consumer or non-health professional from DENMARK reported GABAPENTIN problem on Aug 04, 2006. Female patient, 29 years of age, was diagnosed with epilepsy, neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: fall, sensory loss, thermal burn, unresponsive to stimuli. GABAPENTIN dosage: 800 MG;TID;PO. During the same period patient was treated with CLONAZEPAM. Patient recovered.
Gabapentin Side Effects Report #5086996-6
GABAPENTIN problem was reported by a Consumer or non-health professional from DENMARK on Aug 04, 2006. Female patient, 71 years of age, was diagnosed with diabetic neuropathy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, off label use. GABAPENTIN dosage: 300 MG;TID;PO. During the same period patient was treated with ASPIRIN, CLONIDINE, FOLIC ACID, FUROSEMIDE, GLICLAZIDE, LEVOTHYROXINE, METFORMIN, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5087102-4
Health Professional from UNITED KINGDOM reported GABAPENTIN problem on Aug 07, 2006. Female patient, 66 years of age, weighting 154.3 lb, was diagnosed with pain and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: depression, dizziness, hyperhidrosis, sleep disorder, suicidal ideation. GABAPENTIN dosage: unknown. During the same period patient was treated with PREGABALIN, AZITHROMYCIN, BENDROFLUAZIDE, CODEINE, LATANOPROST, ACETAMINOPHEN. Patient recovered.
Gabapentin Side Effects Report #5090736-4
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on Aug 15, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, blood urea abnormal, confusional state, therapeutic agent toxicity. GABAPENTIN dosage: 600 MG (200 MG, 3 IN 1 D), ORAL. During the same period patient was treated with SPIRONOLACTONE, DIGOXIN, CETIRIZINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5090874-6
Consumer or non-health professional from UNITED KINGDOM reported GABAPENTIN problem on Aug 10, 2006. Female patient, 16 years of age, was diagnosed with epilepsy and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: aggression. GABAPENTIN dosage: (300 MG). During the same period patient was treated with EPILIM. Patient recovered.
Gabapentin Side Effects Report #5091954-1
GABAPENTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, blood urea abnormal, confusional state, therapeutic agent toxicity. GABAPENTIN dosage: 600 MLLIGRAM, ORAL. During the same period patient was treated with SPIRONOLACTONE, DIGOXIN, CETIRIZINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5092959-7
Physician from UNITED KINGDOM reported GABAPENTIN problem on Aug 16, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: blood electrolytes abnormal, blood urea abnormal, confusional state, therapeutic agent toxicity. GABAPENTIN dosage: 200 MG, TID, ORAL. During the same period patient was treated with DIGOXIN, SPIRONOLACTONE, CETIRIZINE, FUROSEMIDE. Patient was hospitalized. Patient recovered.
Gabapentin Side Effects Report #5094003-4
GABAPENTIN problem was reported by a Physician from UNITED KINGDOM on Aug 08, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: muscle twitching, swelling. GABAPENTIN dosage: unknown. During the same period patient was treated with LYRICA. Patient recovered.
Gabapentin Side Effects Report #5094832-7
Health Professional from UNITED STATES reported GABAPENTIN problem on Aug 30, 2006. Female patient was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. GABAPENTIN dosage: 800MG TID PO. Patient recovered.
Gabapentin Side Effects Report #5096788-X
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on Aug 22, 2006. Female patient, 60 years of age, weighting 154.3 lb, was diagnosed with neuralgia and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: joint swelling. GABAPENTIN dosage: 900 MG (300 MG, 3 IN 1 D), ORAL. During the same period patient was treated with AMITRIPTYLINE. Patient recovered.
< Previous Showing 101-150 of 347 Next >
Drug Information: Gabapentin
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a694007.html
(ga' ba pen tin)IMPORTANT WARNING:
| [Posted 01/31/2008] FDA informed healthcare professionals that the Agency has analyzed reports of suicidality (suicidal behavior or ideation) from placebo-controlled clinical studies of eleven drugs used to treat epilepsy as well as psychiatric disorders, and other conditions. In the FDA's analysis, patients receiving antiepileptic drugs had approximately twice the risk of suicidal behavior or ideation (0.43%) compared to patients receiving placebo (0.22%). The increased risk of suicidal behavior and suicidal ideation was observed as early as one week after starting the antiepileptic drug and continued through 24 weeks. The results were generally consistent among the eleven drugs. The relative risk for suicidality was higher in patients with epilepsy compared to patients who were given one of the drugs in the class for psychiatric or other conditions.Healthcare professionals should closely monitor all patients currently taking or starting any antiepileptic drug for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression.The drugs included in the analyses include (some of these drugs are also available in generic form): Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR)Felbamate (marketed as Felbatol)Gabapentin (marketed as Neurontin) Lamotrigine (marketed as Lamictal) Levetiracetam (marketed as Keppra) Oxcarbazepine (marketed as Trileptal)Pregabalin (marketed as Lyrica) Tiagabine (marketed as Gabitril)Topiramate (marketed as Topamax) Valproate (marketed as Depakote, Depakote ER, Depakene, Depacon) Zonisamide (marketed as Zonegran) Although the 11 drugs listed above were the ones included in the analysis, FDA expects that the increased risk of suicidality is shared by all antiepileptic drugs and anticipates that the class labeling changes will be applied broadly. For more information visit the FDA website at: http://www.fda.gov/medwatch/safety/2008/safety08.htm#Antiepileptic and http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. |
Why is this medication prescribed?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Gabapentin is used to help control certain types of seizures in patients who have epilepsy. Gabapentin is also used to relieve the pain of postherpetic neuralgia (PHN; the burning, stabbing pain or aches that may last for months or years after an attack of shingles). Gabapentin is in a class of medications called anticonvulsants. Gabapentin treats seizures by decreasing abnormal excitement in the brain. Gabapentin relieves the pain of PHN by changing the way the body senses pain.
How should this medicine be used?
Gabapentin comes as a capsule, a tablet, and an oral solution (liquid) to take by mouth. It is usually taken with a full glass of water (8 oz) three times a day. Gabapentin may be taken with or without food. Take this medication at evenly spaced times throughout the day and night; do not let more than 12 hours pass between doses. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take gabapentin exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
If your doctor tells you to take one-half of a tablet as part of your dose, carefully split the tablet along the score mark. Use the other half-tablet as part of your next dose. Properly throw away any half-tablets that you have not used within several days of breaking them.
Your doctor will probably start you on a low dose of gabapentin and gradually increase your dose as needed to treat your condition. If you are taking gabapentin to treat PHN, tell your doctor if your symptoms do not improve during your treatment.
Gabapentin may help to control your condition but will not cure it. Continue to take gabapentin even if you feel well. Do not stop taking gabapentin without talking to your doctor. If you suddenly stop taking gabapentin, you may experience withdrawal symptoms such as anxiety, difficulty falling asleep or staying asleep, nausea, pain, and sweating. If you are taking gabapentin to treat seizures and you suddenly stop taking the medication, you may experience seizures more often. Your doctor probably will decrease your dose gradually over at least a week.
Other uses for this medicine
Gabapentin is also sometimes used to relieve the pain of diabetic neuropathy (numbness or tingling due to nerve damage in people who have diabetes), and to treat and prevent hot flashes (sudden strong feelings of heat and sweating) in women who are being treated for breast cancer or who have experienced menopause ( 'change of life', the end of monthly menstrual periods). Talk to your doctor about the risks of using this medication for your condition.
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Before taking gabapentin,
- tell your doctor and pharmacist if you are allergic to gabapentin, any other medications, or any of the inactive ingredients in the type of gabapentin you plan to take. Ask your pharmacist for a list of the inactive ingredients.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: hydrocodone (in Hydrocet, in Vicodin, others), morphine (Avinza, Kadian, MSIR, others), and naproxen (Aleve, Anaprox, Naprosyn, others). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
- if you are taking antacids such as Maalox or Mylanta, take them at least 2 hours before you take gabapentin.
- tell your doctor if you have or have ever had kidney disease.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking gabapentin, call your doctor.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking gabapentin.
- you should know that this medication may make you drowsy or dizzy. Do not drive a car or operate machinery until you know how this medication affects you.
- if you are giving gabapentin to your child, you should know that your child's behavior and mental abilities may change while he or she is taking gabapentin. Your child may have sudden changes in mood, become hostile or hyperactive, have difficulty concentrating or paying attention, or be drowsy or clumsy. Have your child avoid activities that could be dangerous, such as riding a bicycle, until you know how gabapentin affects him or her.
- remember that alcohol can add to the drowsiness caused by this medication.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Gabapentin may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- drowsiness
- tiredness or weakness
- dizziness
- headache
- shaking of a part of your body that you cannot control
- double or blurred vision
- unsteadiness
- anxiety
- memory problems
- strange or unusual thoughts
- unwanted eye movements
- nausea
- vomiting
- heartburn
- diarrhea
- dry mouth
- constipation
- weight gain
- swelling of the hands, feet, ankles, or lower legs
- back or joint pain
- fever
- runny nose, sneezing, cough, sore throat, or flu-like symptoms
- ear pain
- red, itchy eyes (sometimes with swelling or discharge)
Some side effects may be serious. If you experience any of the following symptoms, call your doctor immediately:
- rash
- itching
- swelling of the face, throat, tongue, lips, eyes, hands, feet, ankles, or lower legs
- hoarseness
- difficulty swallowing or breathing
- seizures
Gabapentin may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store the tablets and capsules at room temperature, away from excess heat and moisture (not in the bathroom). Store the oral solution in the refrigerator. Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
Symptoms of overdose may include:
- double vision
- slurred speech
- drowsiness
- diarrhea
What other information should I know?
Pending revision, the material in this section should be considered in light of more recently available information in the MedWatch notification at the beginning of this monograph.
Keep all appointments with your doctor.
Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking gabapentin.
If you use a dipstick to test your urine for protein, ask your doctor which product you should use while taking this medication.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|